Skip to content

Centre Hospitalier Universitaire de Montpellier (CHUM)

CHUM is the 6th largest French public hospital, affiliated with the University of Montpellier.
The Department of Endocrinology, Diabetes and Nutrition (DEDN) is involved in the development and assessment of innovative technologies dedicated to diabetes care, including portable and implantable insulin pumps, continuous glucose monitoring (CGM) systems, artificial pancreas (AP) models, as well as pancreas and islet transplantations. It holds a specific unit for education and follow-up of patients using technologies for diabetes care.

The DEDN at CHUM includes 56 beds dedicated to patient care specialized in diabetes, endocrine and metabolic diseases. Clinical care activity in 2017 included 12000 cumulated days for hospitalized patients and 10000 outpatient visits.

The DEDN is affiliated to the Medical School of the University of Montpellier. Its teaching and research staff comprises 3 full professors and 2 chief residents. Seven medical practitioners, 1 surgeon specialist in implantation of artificial devices and 1 medical research practitioner (Dr Anne Farret), 1 post-doctoral fellow, 1 research engineer (Jerome Place) and 1 research assistant are also included in the permanent staff dedicated to diabetes technology. Seven residents/fellows are currently hosted in DEDN. Its research activities are developed in the UMR CNRS 9203/INSERM U1191 Research Institute at the University of Montpellier. The two leading research domains include the clinical assessment of innovative insulin delivery systems connected to glucose sensing devices for the development of artificial pancreas models, and the performance of islet transplantation in patients with type 1 diabetes. The Department is currently coordinated by Professor Eric Renard, MD, PhD, who also coordinates the Clinical Investigation Centre INSERM 1411 at CHUM.

The DEDN shares a long-term partnership with the Department of Gut Surgery both for patient care activities (bariatric surgery) and clinical research activities in diabetes, metabolic surgery and pancreas transplantation (Professor Fabrizio Panaro). This research partnership allows an access to the Investigational Surgery facility at Montpellier Medical School for experiments in animals.

Prof. Eric Renard


Prof. Eric Renard, MD, PhD (male), holds a Chair of Professor of Endocrinology, Diabetes & Metabolism at Montpellier Medical School, University of Montpellier, since 1999, and the Head of the Department of Endocrinology, Diabetes and Nutrition, at Lapeyronie University Hospital, Montpellier, since 2010. Eric Renard was also Medical Director of Clinical Research at Montpellier University Hospital (2008-18) and is Head of the INSERM 1411 Clinical Research Centre at Montpellier University Hospital since January 2010. 

He leads a research team focusing on ‘Determinants and correction of the loss of insulin secretion in diabetes’ at the Institute of Functional Genomics, UMR CNRS 5203/INSERM U1191/ University of Montpellier, Montpellier, since 2012. Professor Renard devoted his work on developing insulin pump therapy, intra-peritoneal insulin delivery and closed-loop insulin delivery systems and authored more than 250 peer-reviewed papers.

Research Group

Dr. Anne Farret

Dr. Anne Farret, MD, PhD (female), holds a position of Senior Clinical Research investigator at Montpellier University Hospital in the Department of Endocrinology, Diabetes and Nutrition. She has a broad expertise in the evaluation of medical devices dedicated to diabetes monitoring, therapy and control, including insulin pumps, CGM systems and artificial pancreas in outpatients.

Pr. Fabrizio Panaro

Pr. Fabrizio Panaro, MD, PhD (Male), is surgeon of the Montpellier Medical Center, Department of Surgery in the College of Medicine at Montpellier, and as a Professor of Surgery for the Montpellier University. Professor Panaro’s main fields of activity and research are surgery of the liver, biliary tract and pancreas, and liver/pancreas transplantation.

He is permanent Visiting Professor of Surgery at the University of Illinois at Chicago (UIC). He is particularly involved in the treatment of hepatocellular carcinoma and of liver metastases. Highly interested in new technologies, the miniinvasive and robotic surgery. He has delivered more than 200 lectures on his research interests around
the world, and has more than 120 publications in peer-reviewed journals. He is member-at-large of International Hepato-Pancreato-Biliary Association (IHPBA) and of the International Pancreas Ilets Transplant Association (IPITA). He currently serves on the editorial board for a number of prestigious journals. Fabrizio Panaro holds a specific expertise in investigational surgery that he performs at the
facility for research in animals of Montpellier Medical School.

Jérôme Place

Jérôme Place, MSc (male), is a senior research engineer at the Institute of Functional Genomics, UMR CNRS 5203/INSERM U1191/ University of Montpellier, Montpellier, working in the team led by Prof. Renard. He is coordinator of many clinical studies dedicated to diabetes technology and has developed remote monitoring systems used for the investigation of outpatients testing artificial pancreas systems.

He is also data manager of multicenter clinical studies of insulin delivery and CGM systems and holds ability of statistical analyses.


CHUM will be involved in:

WP1: Hormone refilling strategy

WP3: Intra-peritonal Model Predictive Control (MPC) and Novel intra-peritoneal T1D simulator

WP4 (leader): Implantation surgical procedures and preclinical BIP validation

WP6: Clinical validation of ip control algorithm (based on sc glucose sensing & DiaPort), First-in-human testing of BIP components, First-in-human investigations.

WP7: Exploitation/innovation and dissemination

Do you want to receive news and updates on the project?

Fill out the form to receive news about the project

Subscribe to the newsletter

Subscribe to


Join our mailing to receive the latest news and updates on the project.

Information on personal-data processing by the FORGETDIABETES website

Information pursuant to Articles 13 and 14 of EU Regulation 2016/679
Pursuant to Articles 13 and 14 of EU Regulation 2016/679 on data protection (GDPR), we inform you that the personal data you provided voluntarily to the University of Padova will be processed by adopting suitable measures to ensure their safety and confidentiality in full compliance with the GDPR.

 1. Purposes and methods of data processing 

1.1. Navigation data. 
The information systems that run the FORGETDIABETES website ( automatically acquire on a daily basis some of the personal data transmitted when web communication protocols are used. If these personal data are processed with data held by third parties, they could identify users and/or visitors. These personal data include the IP address and computer domain names used to connect to These data are normally collected for anonymous statistical surveys and are used to make it easier to navigate

1.2. Cookies.
The FORGETDIABETES website uses cookies, i.e. small text files that are sent from the website’s server to your browser and are automatically saved on your computer. They are used for statistical surveys for the sole purposes of improving the University’s services and we therefore recommend you configure your browser to accept them. The vast majority of browsers are configured to accept cookies; you can, however, change your browser settings to block them. See point 1.2.2 “How to disable cookies (opting-out)”.

1.2.1. Cookies
Cookies can be disabled without having any effect on your website experience. The University uses Google Analytics, a service provided by Google Inc., (hereinafter called “Google”) to generate statistics on how its website is used. Google Analytics uses cookies, but they do not store your personal data and are not third-party. Cookies contain information on your website use, including your IP address, and will be sent by your browser to Google, which is based at 1600 Amphitheatre Parkway, Mountain View, CA 94043, United States, where they will be stored on the company’s servers. In accordance with the current terms of service, Google will use this information in its role as an independent data processor to track and examine website use, draw up reports on website-activity, and provide services related to your website-activity, device (e.g. mobile phone, pc, browser) and how you search for and arrive at the information you require. Google may also send this information to third parties to meet legal requirements or when said third parties process your information on behalf of Google. Google will not associate your IP address with any other data in its possession.
To consult Google’s privacy information for its Google Analytics service, please visit
To read more about Google’s privacy policy, please visit
When you use the University’s website, you consent to having your personal data processed by Google in the above ways and for the above purposes. 

1.2.2. How to disable cookies (opting-out)
If you do not want to consent to the use of cookies, you can disable them by changing your browser settings. Browsing the website as an unauthenticated user does not hinder any of the website’s functions. Below are links that explain how to disable cookies on the main browsers. If you use another browser, we suggest you look for the “disable cookies” in the “help” option. This option is normally available by pressing F1.
Internet Explorer:
Google Chrome:
Mozilla Firefox:
Apple Safari:
Alternatively, you can choose to disable Google Analytics cookies only by installing Google’s opt-out add-on, which it provides for the main browsers.

1.2.3. Remarketing e Behavioral Targeting

Facebook Custom Audience (Facebook, Inc.) 
Facebook Custom Audience is a remarketing and behavioral targeting service provided by Facebook, Inc. that connects the activity of this Website with the Facebook advertising network.
Personal Data collected: Cookies; email address.
Place of processing: United States – Privacy Policy – Opt Out. Privacy Shield participant.

Facebook Remarketing (Facebook, Inc.)

Facebook Remarketing is a remarketing and behavioral targeting service provided by
Facebook, Inc. that connects the activity of this Website with the Facebook advertising network.
Personal Data collected: Cookies; Usage Data.
Place of processing: United States – Privacy Policy – Opt Out. Privacy Shield participant.

1.3 Purposes and storage of data 
Collected data are processed for statistical analysis for the sole purposes of improving services; therefore, they will be stored for the minimum time needed to perform a service.

1.4. Data processing
Your data will be processed manually, as well as by electronic and automated means, for the following purposes in accordance with the limits and conditions of the General Data Protection Regulation (GDPR) 2016/679: collection, recording, organisation, storage, adaptation or alteration, retrieval, consultation, use, disclosure by transmission, dissemination or otherwise making available, alignment or combination, restriction, erasure or destruction.

2. Disclosure and dissemination of data
Your personal data will not be disseminated or disclosed to third parties unless provided for by the University’s dataprocessing information and/or by the law. In these cases, data will be disclosed and/or disseminated in accordance with the methods allowed.
Your data may be disclosed to processors or to persons tasked with processing as part of their job and in accordance with the instructions they receive, but solely for the purposes stated in this information.

3. Rights of the data subject
Regarding your personal data, you may exercise the rights provided for by the General Data Protection Regulation 2016/679 by sending an email to: [email protected]

4. Data Controller 
The Data Controller is the University of Padova, which is based at Via VIII Febbraio no. 2, Padova, Italy. A complete list of data processors can be consulted at this address.

5. Contact details of the Data-protection officer
You can contact the University’s Data-protection officer at: [email protected].

Updated on: 31 May 2019